Ziying Jian

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Zhiheng Zhang · 3 shared papers, 2018–2025 · strength 0.40
   • Paper AGR2 suppresses ferroptosis via the p53/FPN1 regulatory axis and drives therapeutic vulnerabilities in pancreatic cance… DOI 10.1038/s41419-025-08263-y↗
   • Paper Topically applicated curcumin/gelatin-blended nanofibrous mat inhibits pancreatic adenocarcinoma by increasing ROS prod… DOI 10.1186/s12951-020-00687-2↗
   • Paper Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2018.07.003↗
2. Zhiheng Zhang · 1 shared paper, 2025 · strength 0.26
   • Paper Comprehensive analysis of UPK3B as a marker for prognosis and immunity in pancreatic adenocarcinoma. DOI 10.1038/s41598-025-97213-x↗
3. Shi Zuo · 1 shared paper, 2025 · strength 0.22
   • Paper AGR2 suppresses ferroptosis via the p53/FPN1 regulatory axis and drives therapeutic vulnerabilities in pancreatic cance… DOI 10.1038/s41419-025-08263-y↗
4. Tao Cheng · 2 shared papers, 2018–2020 · strength 0.18
   • Paper Topically applicated curcumin/gelatin-blended nanofibrous mat inhibits pancreatic adenocarcinoma by increasing ROS prod… DOI 10.1186/s12951-020-00687-2↗
   • Paper Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2018.07.003↗
5. Xinyi Dai · 1 shared paper, 2020 · strength 0.12
   • Paper Topically applicated curcumin/gelatin-blended nanofibrous mat inhibits pancreatic adenocarcinoma by increasing ROS prod… DOI 10.1186/s12951-020-00687-2↗
6. Kuangyu Shi · 1 shared paper, 2018 · strength 0.06
   • Paper Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2018.07.003↗
7. Simone Benitz · 1 shared paper, 2018 · strength 0.06
   • Paper Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2018.07.003↗
8. Shanshan Shen · 1 shared paper, 2018 · strength 0.06
   • Paper Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2018.07.003↗
9. Shuang Nie · 1 shared paper, 2018 · strength 0.06
   • Paper Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2018.07.003↗
10. Christoph W. Michalski · 1 shared paper, 2018 · strength 0.06
    • Paper Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2018.07.003↗
11. Helmut Friess · 1 shared paper, 2018 · strength 0.06
    • Paper Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2018.07.003↗
12. Jorg H. Kleeff · 1 shared paper, 2018 · strength 0.06
    • Paper Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2018.07.003↗
13. Bo Kong · 1 shared paper, 2018 · strength 0.06
    • Paper Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2018.07.003↗
14. Peilin Huang · 1 shared paper, 2018 · strength 0.06
    • Paper Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2018.07.003↗
15. Xiaoping Zou · 1 shared paper, 2018 · strength 0.06
    • Paper Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2018.07.003↗
16. Guralp Onur Ceyhan · 1 shared paper, 2018 · strength 0.06
    • Paper Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2018.07.003↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.